Il y a eu 50 transactions d'initiés récentes enregistrées pour Bausch Health Companies Inc. (BHC), dont 30 achats et 15 ventes. Le total des achats d'initiés s'élève à $376.15M et le total des ventes d'initiés à $10.57M.
Les initiés notables ayant une activité récente comprennent Leung Sandra, Paulson John, Wechsler Amy B. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — BHC
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-31 |
Leung Sandra |
Director |
Attribution de RSU |
5,946 |
$5.40 |
$32.11K |
44,354 |
| 2026-03-31 |
Paulson John |
Director |
Attribution de RSU |
11,574 |
$5.40 |
$62.5K |
371,694 |
| 2026-03-31 |
Wechsler Amy B |
Director |
Attribution de RSU |
1,273 |
$5.40 |
$6.87K |
267,714 |
| 2026-03-03 |
Carson Seana |
EVP, General Counsel |
Vente Informative |
4,420 |
$5.77 |
$25.5K |
616,761 |
| 2026-03-02 |
Appio Thomas |
Chief Executive Officer |
Autre (Vente) |
1,137,862 |
$5.95 |
$6.77M |
2,315,374 |
| 2026-03-02 |
Carson Seana |
EVP, General Counsel |
Autre (Vente) |
137,922 |
$5.95 |
$820.64K |
621,181 |
| 2026-02-27 |
Carson Seana |
EVP, General Counsel |
Vente Informative |
8,388 |
$5.95 |
$49.91K |
809,258 |
| 2026-02-27 |
Appio Thomas |
Chief Executive Officer |
Retenue Fiscale RSU |
83,093 |
$5.93 |
$492.74K |
3,536,941 |
| 2026-02-27 |
Charhon Jean-jacques |
EVP, CFO |
Retenue Fiscale RSU |
49,060 |
$5.93 |
$290.93K |
706,478 |
| 2026-02-27 |
Carson Seana |
EVP, General Counsel |
Retenue Fiscale RSU |
26,326 |
$5.93 |
$156.11K |
782,932 |
| 2026-02-26 |
Appio Thomas |
Chief Executive Officer |
Retenue Fiscale RSU |
116,502 |
$6.04 |
$703.67K |
3,620,034 |
| 2026-02-26 |
Charhon Jean-jacques |
EVP, CFO |
Retenue Fiscale RSU |
35,977 |
$6.04 |
$217.3K |
755,538 |
| 2026-02-26 |
Carson Seana |
EVP, General Counsel |
Retenue Fiscale RSU |
32,211 |
$6.04 |
$194.55K |
817,646 |
| 2026-02-26 |
Lenar Aimee J. |
EVP, Us Pharma |
Retenue Fiscale RSU |
17,578 |
$6.04 |
$106.17K |
400,335 |
| 2026-02-25 |
Appio Thomas |
Chief Executive Officer |
Attribution de RSU |
815,425 |
- |
- |
3,736,536 |
| 2026-02-25 |
Charhon Jean-jacques |
EVP, CFO |
Attribution de RSU |
276,055 |
- |
- |
791,515 |
| 2026-02-25 |
Lee Steven Hyosig |
SVP, Controller & CAO |
Attribution de RSU |
45,868 |
- |
- |
73,239 |
| 2026-02-25 |
Carson Seana |
EVP, General Counsel |
Attribution de RSU |
212,350 |
- |
- |
849,857 |
| 2026-02-25 |
Lenar Aimee J. |
EVP, Us Pharma |
Attribution de RSU |
157,139 |
- |
- |
417,913 |
| 2026-02-09 |
Appio Thomas |
Chief Executive Officer |
Attribution de RSU |
1,137,862 |
- |
- |
2,921,111 |
| 2026-02-09 |
Carson Seana |
EVP, General Counsel |
Attribution de RSU |
137,922 |
- |
- |
637,507 |
| 2025-12-31 |
Leung Sandra |
Director |
Attribution de RSU |
4,586 |
- |
- |
38,408 |
| 2025-12-31 |
Paulson John |
Director |
Attribution de RSU |
8,992 |
- |
- |
360,120 |
| 2025-12-31 |
Wechsler Amy B |
Director |
Attribution de RSU |
989 |
- |
- |
266,441 |
| 2025-11-25 |
Paulson & Co. Inc. |
10 Percent Owner |
Achat Informatif |
2,500,000 |
$6.25 |
$15.63M |
73,255,869 |
| 2025-09-30 |
Leung Sandra |
Director |
Attribution de RSU |
3,673 |
- |
- |
33,822 |
| 2025-09-30 |
Paulson John |
Director |
Attribution de RSU |
9,689 |
- |
- |
351,128 |
| 2025-09-30 |
Wechsler Amy B |
Director |
Attribution de RSU |
1,065 |
- |
- |
265,452 |
| 2025-09-30 |
Paulson John |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-09-08 |
Carson Seana |
EVP, General Counsel |
Vente Informative |
13,370 |
$7.31 |
$97.73K |
499,585 |
| 2025-09-05 |
Carson Seana |
EVP, General Counsel |
Retenue Fiscale RSU |
51,337 |
$7.35 |
$377.33K |
512,955 |
| 2025-08-21 |
Lee Frank D. |
Director |
Vente Informative |
15,912 |
$7.66 |
$121.89K |
73,795 |
| 2025-08-14 |
Paulson & Co. Inc. |
10 Percent Owner |
Inconnu |
- |
- |
- |
70,755,869 |
| 2025-08-14 |
Paulson John |
Director |
Achat Informatif |
34,721,118 |
$9.00 |
$312.49M |
70,755,869 |
| 2025-08-13 |
Paulson John |
Director |
Achat Informatif |
86,409 |
$7.06 |
$610.05K |
36,034,751 |
| 2025-08-12 |
Paulson John |
Director |
Achat Informatif |
1,156,640 |
$6.88 |
$7.96M |
35,948,342 |
| 2025-08-11 |
Paulson John |
Director |
Achat Informatif |
2,000,000 |
$6.35 |
$12.7M |
34,791,702 |
| 2025-07-25 |
Leung Sandra |
Director |
Attribution de RSU |
30,149 |
- |
- |
30,149 |
| 2025-07-25 |
Goettler Michael |
Director |
Attribution de RSU |
30,149 |
- |
- |
30,149 |
| 2025-07-22 |
Leung Sandra |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-07-22 |
Goettler Michael |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-07-17 |
Lenar Aimee J. |
EVP, Us Pharma |
Attribution de RSU |
30,847 |
- |
- |
260,774 |
| 2025-07-15 |
Lenar Aimee J. |
EVP, Us Pharma |
Retenue Fiscale RSU |
22,736 |
$6.42 |
$145.97K |
229,927 |
| 2025-07-14 |
Lee Steven Hyosig |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-07-14 |
Lee Steven Hyosig |
SVP, Controller & CAO |
Attribution de RSU |
27,371 |
- |
- |
27,371 |
| 2025-06-30 |
Icahn Brett |
Director |
Attribution de RSU |
4,034 |
- |
- |
220,280 |
| 2025-06-30 |
Paulson John |
Director |
Attribution de RSU |
9,384 |
- |
- |
341,439 |
| 2025-06-30 |
Wechsler Amy B |
Director |
Attribution de RSU |
1,032 |
- |
- |
264,387 |
| 2025-06-13 |
Paulson John |
Director |
Achat Informatif |
3,564,059 |
$5.94 |
$21.17M |
32,791,702 |
| 2025-06-12 |
Paulson John |
Director |
Achat Informatif |
1,005,376 |
$5.47 |
$5.5M |
29,227,643 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
